| Literature DB >> 34075123 |
Isabella Karakis1, Yael Baumfeld2, Daniella Landau3, Roni Gat4,5, Nofar Shemesh6, Maayan Yitshak-Sade7, Ofir Tirosh8, Batia Sarov9, Lena Novack10,11,12.
Abstract
This exploratory study was aimed to investigate the link between toxic metal content in women's urine and their morbidity 2 years before and 6 years after the test. Concentrations of 25 metals in urine were analyzed for 111 pregnant women collected prior to delivery. All women were of Arab-Bedouin origin. Information on primary care and hospital visits during the study period was obtained. In a Poisson regression model, a health outcome was regressed over metal exposure and other factors. A Weighted Quantile Sum Regression (WQS) approach was used to indicate metals dominating in their possible impact on women's morbidity. Obesity was the most frequently diagnosed condition in this population (27.9%). Diagnoses in a neurological category accounted for 36.0%, asthma or respiratory-25.2%, psychiatric-12.6%, cardiovascular-14.4% and cancer or benign growth-for 13.5%. Based on WQS analysis, cancer and benign growth were mostly attributed to the increased levels of cadmium, cardiovascular outcomes were linked with lead, and obesity was found associated with elevated levels of nickel. Hematological, neurological and respiratory outcomes were attributed to multiple non-essential metals. The health and exposure profile of women in the study warrants a periodic biomonitoring in attempt to identify and reduce exposure to potentially dangerous elements.Entities:
Year: 2021 PMID: 34075123 PMCID: PMC8169725 DOI: 10.1038/s41598-021-90904-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic characteristics of the study population.
| Subjects’ characteristics | Study sample (N = 111 newborns) (N = 111 deliveries) |
|---|---|
| Maternal age, years | |
| Median | 26.9 |
| Min; Max | 18.4; 41.7 |
| Parity | |
| 1 | 27.3 (30/110) |
| 2–5 | 42.7 (47/110) |
| 6 + | 30.0 (33/110) |
| Residing in a temporary shack/tent, % (n/N) | 29.5 (18/61) |
| Cooking on open fire, % (n/N) | 74.6 (41/55) |
| Consanguineous marriage, % (n/N) | 72.2 (39/54) |
| Hematological, % (n/N) | 5.4 (6/111) |
| Cancer/Benign, % (n/N) | 13.5 (15/111) |
| Cardiovascular, % (n/N) | 14.4 (16/111) |
| Psychiatric, % (n/N) | 12.6 (14/111) |
| Obesity, % (n/N) | 27.9 (31/111) |
| Diabetes Mellitus, % (n/N) | 8.1 (9/111) |
| Neurological, % (n/N) | 36.0 (40/111) |
| Asthma/Respiratory % (n/N) | 25.2 (28/111) |
Association between internal dose of metals in quartiles and presence of a clinical outcome at follow-up expressed as Prevalence Ratio (PR), (p-value)1,2.
| Metal3 (n = 111) | Geometric mean | 95% CI | Hematology (n = 6) vs none (n = 105) | Cancer/benign (n = 15) vs none (n = 96) | Cardiovascular (n = 16) vs none (n = 95) | Psychiatric (n = 14) vs none (n = 97) | Obesity (n = 31) vs none (n = 80) | DM (n = 9) vs none (n = 102) | Neurological (n = 40) vs none (n = 71) | Asthma/respiratory (n = 28) vs none (n = 83) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biometals | Na, ppm | 1629.3 | 969.3; 2738.7 | 1.11 (.774) | 1.48 (.129) | 0.96 (.844) | 0.71 (.082) | 1.23 (.140) | 0.93 (.824) | 1.18 (.126) | 0.97 (.816) |
| K, ppm | 998.9 | 604.8;649.6 | 0.64 (.774) | 1.16 (.463) | 1.07 (.734) | 0.91 (.677) | 1.36 (.027) | 1.24 (.439) | 1.18 (.142) | 1.00 (.975) | |
| Mg, ppm | 15.2 | 9.4; 24.4 | 1.13 (.603) | 1.20 (.398) | 1.15 (.470) | 1.00 (.997) | 1.23 (.132) | 1.06 (.823) | 0.99 (.933) | 0.94 (.671) | |
| Ca, ppm | 19.7 | 12.3; 31.5 | 1.11 (.752) | 1.30 (.231) | 1.02 (.939) | 1.21 (.327) | 1.26 (.091) | 1.04 (.874) | 1.07 (.549) | 1.26 (.097) | |
| Se, ppb | 19.6 | 13.7; 27.9 | 0.85 (.644) | 1.23 (.374) | 1.31 (.174) | 1.15 (.522) | 1.23 (.142) | 1.03 (.913) | 1.00 (.965) | 0.97 (.836) | |
| Zn, ppb | 146.5 | 93.6; 229.3 | 1.07 (.786) | 1.27 (.261) | 1.28 (.115) | 1.11 (.653) | 1.16 (.306) | 1.19 (.548) | 1.13 (.267) | 0.91 (.508) | |
| Cu, ppb | 12.1 | 8.6; 17.1 | 0.73 (.378) | 1.29 (.200) | 1.06 (.805) | 1.01 (.976) | 1.36 (.032) | 0.99 (.970) | 1.16 (.197) | 0.88 (.334) | |
| Non-essential metals | Li, ppb4 | 6.6 | 4.6; 9.4 | 0.89 (.706) | 1.36 (.169) | 1.33 (.247) | – | 1.02 (.908) | 1.25 (.529) | 1.10 (.442) | 0.72 (.026) |
| Co, ppb | 0.9 | 0.7; 1.2 | 0.87 (.638) | 0.92 (.653) | 1.09 (.636) | 1.11 (.575) | 1.20 (.177) | 0.94 (.824) | 1.03 (.783) | 0.99 (.943) | |
| Ni, ppb | 1.2 | 1.0; 1.6 | 0.97 (.931) | 1.47 (.108) | 1.07 (.730) | 1.02 (.906) | 1.27 (.087) | 0.99 (.982) | 1.05 (.672) | 0.92 (.509) | |
| Tl, ppb | 0.04 | 0.0; 0.1 | 1.72 (.023) | 1.47 (.072) | 1.11 (.613) | 0.79 (.201) | 1.05 (.717) | 0.95 (.837) | 0.93 (.463) | 0.87 (.292) | |
| Al, ppb | 6.1 | 3.8; 9.9 | 1.30 (.497) | 1.12 (.608) | 1.08 (.700) | 0.76 (.247) | 1.39 (.026) | 1.04 (.919) | 0.91 (.387) | 0.89 (.437) | |
| Cr, ppb | 0.6 | 0.4; 0.9 | 2.09 (.073) | 1.07 (.680) | 1.10 (.678) | 1.44 (.086) | 0.99 (.921) | 0.70 (.299) | 1.06 (.575) | 0.94 (.697) | |
| Sr, ppb | 72.7 | 48.3; 109.7 | 1.46 (.209) | 1.16 (.471) | 1.24 (.209) | 1.21 (.329) | 1.19 (.213) | 0.81 (.482) | 1.07 (.563) | 1.15 (.331) | |
| Ba, ppb | 1.3 | 0.9; 1.9 | 1.24 (.434) | 0.91 (.668) | 1.15 (.488) | 1.34 (.218) | 1.19 (.190) | 0.65 (.181) | 1.20 (.101) | 1.13 (.339) | |
| Cd, ppb | 0.2 | 0.2; 0.3 | 1.24 (.517) | 1.75 (.020) | 1.05 (.802) | 1.05 (.801) | 1.05 (.742) | 1.12 (.682) | 1.08 (.448) | 0.90 (.448) | |
| Be, ppb | 0.1 | 0.1; 0.2 | 0.81 (.434) | 0.82 (.295) | 0.74 (.120) | 1.26 (.321) | 1.18 (.180) | 1.00 (.988) | 1.11 (.353) | 1.11 (.450) | |
| V, ppb | 0.04 | 0.0; 0.1 | 1.13 (.666) | 1.26 (.240) | 1.40 (.082) | 0.78 (.202) | 1.22 (.097) | 1.34 (.287) | 1.08 (.454) | 1.01 (.938) | |
| As, ppb | 3.6 | 2.3; 5.5 | 1.31 (.438) | 1.43 (.039) | 1.36 (.102) | 0.79 (.310) | 1.06 (.633) | 0.96 (.898) | 1.21 (.074) | 0.83 (.209) | |
| Fe, ppb | 1.2 | 0.5; 2.5 | 1.34 (.438) | 1.24 (.231) | 1.21 (.470) | 0.75 (.194) | 1.25 (.069) | 0.94 (.806) | 1.06 (.567) | 0.99 (.946) | |
| Mo, ppb | 7.2 | 3.9; 13.6 | 1.15 (.668) | 1.38 (.132) | 1.11 (.589) | 1.28 (.191) | 1.05 (.724) | 0.89 (.734) | 1.01 (.908) | 0.72 (.027) | |
| Mn, ppb | 0.03 | 0.02; 0.04 | 1.34 (.774) | 1.05 (.759) | 1.41 (.027) | 1.01 (.965) | 0.86 (.284) | 1.32 (.262) | 1.09 (.333) | 1.13 (.297) | |
| Ag, ppb | 0.04 | 0.0; 0.1 | 1.12 (.710) | 1.05 (.790) | 1.74 (.001) | 0.86 (.502) | 1.08 (.494) | 1.04 (.900) | 1.05 (.586) | 1.05 (.654) | |
| Pb, ppb | 0.2 | 0.1; 0.3 | 1.72 (.138) | 0.90 (.527) | 1.38 (.084) | 0.95 (.800) | 1.00 (.966) | 1.05 (.857) | 0.86 (.127) | 0.96 (.732) | |
| U, ppb | 0.01 | 0.01; 0.01 | 1.41 (.280) | 1.10 (.623) | 0.91 (.668) | 0.73 (.294) | 0.81 (.187) | 1.01 (.958) | 0.88 (.364) | 0.86 (.336) | |
| Any non-essential metal in 4th quartile, % (n/N) | |||||||||||
| in the group with disease | 100.0 (6) | 100.0 (15) | 100.0 (16) | 92.9 (13) | 87.1 (27) | 77.8 (7) | 95.0 (38) | 96.4 (27) | |||
| in the group without disease | 84.8 (89) | 83.3 (80) | 83.2 (79) | 84.5 (82) | 85.0 (68) | 83.6 (88) | 80.3 (57) | 84.3 (70) | |||
| p-value for comparison | 0.301 | 0.087 | 0.076 | 0.407 | 0.778 | 0.487 | 0.034 | 0.096 | |||
| Number of non-essential metals in 4th quartile | |||||||||||
| In the group with disease Median | 4.0 | 5.0 | 5.5 | 4.0 | 5.0 | 5.0 | 4.0 | 3.5 | |||
| In the group without disease Median | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | |||
| p-value for comparison | 0.560 | 0.440 | 0.076 | 0.617 | 0.271 | 0.656 | 0.753 | 0.388 | |||
1The table presents a Prevalence Ratio (PR) reflecting a multiplicative variation in the metals' concentrations associated with presence of a health outcome, adjusted to age. Age was statistically associated with the cardio-vascular outcome, psychiatric morbidity, obesity and diabetes mellitus.
2Estimates with p-value < 0.1 are shaded.
3Li values in subjects with a psychiatric diagnosis were defined as missing.
Figure 1Metals' burden on morbidity. Results of Weighted Quantile Sum Regression analysis.